CROs

Pfizer doubles down on Syneos Health with new services pact
Pfizer doubles down on Syneos Health with new services pact
Fierce Biotech
Pfizer
CROs
Syneos Health
Flag link:
Charles River expects hit of up to $215M from COVID-19
Charles River expects hit of up to $215M from COVID-19
Fierce Biotech
Charles River Labs
CROs
COVID-19
pandemic
Flag link:
Icon to slash costs amid pandemic as 65% of its trial sites disrupted by COVID-19
Icon to slash costs amid pandemic as 65% of its trial sites disrupted by COVID-19
Fierce Biotech
ICON
COVID-19
layoffs
clinical trial recruitment
clinical trials
pandemic
CROs
Flag link:
Life science companies combine to form COVID-19 research database
Life science companies combine to form COVID-19 research database
Fierce Biotech
CROs
life sciences
data analytics
R&D
database
Flag link:
Pfizer signs up for longer pact with Icon, pens extra 2-year clause
Pfizer signs up for longer pact with Icon, pens extra 2-year clause
Fierce Biotech
Pfizer
ICON
CROs
R&D
Flag link:
J&J's favorite CAR-T developer, currently owned by a Chinese CRO, is laying the groundwork for US IPO
J&J's favorite CAR-T developer, currently owned by a Chinese CRO, is laying the groundwork for US IPO
Endpoints
CAR-T
IPOs
GenScript
CROs
China
JNJ
Flag link:
CROs, clinical researchers brace for impact of coronavirus shutdown across China
CROs, clinical researchers brace for impact of coronavirus shutdown across China
Fierce Biotech
China
coronavirus
COVID-19
clinical trials
CROs
Flag link:
Drug research firm PPD prices IPO at top end of target
Drug research firm PPD prices IPO at top end of target
Reuters
IPOs
CROs
PPD
Flag link:
PPD Files the Paperwork for $100 Million IPO
PPD Files the Paperwork for $100 Million IPO
CP WIre
PPD
CROs
IPOs
Flag link:
PPD Files the Paperwork for $100 Million IPO
PPD
CROs
IPOs
Flag link:
Worldwide Clinical Trials to Use Novel Platform to Address Phase I Trial Challenges
Worldwide Clinical Trials to Use Novel Platform to Address Phase I Trial Challenges
Xtalks
Worldwide Clinical Trials
clinical trials
CROs
Flag link:
Once 'bodies for hire,' CROs are finding a new role as data specialists
Once 'bodies for hire,' CROs are finding a new role as data specialists
Biopharma Dive
CROs
RWE
real world data
Flag link:
WuXi AppTec buys clinical research services firm Pharmapace
WuXi AppTec buys clinical research services firm Pharmapace
Pharmaceutical Business Review
CROs
M&A
WuXi AppTec
Pharmapace
Flag link:
Charles River swoops on early-stage CRO Citoxlab
Charles River swoops on early-stage CRO Citoxlab
Fierce Biotech
Charles River Labs
M&A
Citoxlab
CROs
R&D
Flag link:
Lawsuit Alleges Racial Discrimination at Charles River Laboratories S.C. Facility
Lawsuit Alleges Racial Discrimination at Charles River Laboratories S.C. Facility
BioSpace
Charles River Laboratories
CROs
racial discrimination
Flag link:
CEL-SCI wins $2.9M in CRO legal battle
CEL-SCI wins $2.9M in CRO legal battle
Medical Design and Outsourcing
Cel-Sci
CROs
breach-of-contract
Flag link:
Pfizer latest pharma to join TriNetX, aims to boost real world data use
Pfizer latest pharma to join TriNetX, aims to boost real world data use
Fierce Biotech
Pfizer
clinical trials
CROs
TriNetX
Flag link:
CROs team up to develop shared tech standards
CROs team up to develop shared tech standards
Biopharma Dive
CROs
Align Clinical CRO
clinical trials
Flag link:
Biotech CEOs: Working with CROs is challenging
Biotech CEOs: Working with CROs is challenging
Biopharma Dive
biotech
CROs
R&D
Flag link:
Single-source contracting could speed drug development
Single-source contracting could speed drug development
BioPharma Dive
drug development
R&D
CMOs
CROs
Flag link:

Pages